
Canbio Pharmaceuticals LLP
About Canbio Pharmaceuticals LLP
Data last updated:
Canbio Pharmaceuticals LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 June 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAS-5978. Its GSTIN is 24AAPFC4083N1ZZ (Gujarat).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Bhupendrabhai Valjibhai Patel and Rabindra Kumar Mohanty.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Plot No 247 248 1 Phase 1 G.I.D.C Naroda, Ahmedabad, Gujarat, India – 382330.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹9.1 Cr, a growth of 121% compared to the previous year. For the same year it recorded a net profit of ₹12.33 Lakh (net margin 1.4%) and EBITDA of ₹70.93 Lakh (EBITDA margin 7.8%).
As per MCA filings, the LLP has open charges of ₹7.15 Cr on record.
Company details
Contact details
Canbio Pharmaceuticals LLP's registered office is in Ahmedabad, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 247 248 1 Phase 1 G.I.D.C Naroda, Ahmedabad, Gujarat, India – 382330
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Canbio Pharmaceuticals LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Canbio Pharmaceuticals LLP
FY 2025 filings availableCanbio Pharmaceuticals LLP reported revenue of ₹9.1 Cr (up 121% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 121% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | ||||
| Other Income | ||||
| Total Income | ₹9.1 Cr | |||
| Purchases and Direct Costs | ||||
| Personnel Expenses | ||||
| Administrative Expenses | ||||
| Interest | ||||
| Depreciation | ||||
| Total Expenses | ||||
| Profit Before Tax | ||||
| Tax | ||||
| Profit After Tax | ₹12.33 Lakh | |||
| Profit Transferred to Partners | ||||
| Assets and Liabilities | ||||
| Partners' Contribution | ||||
| Reserves and Surplus | ||||
| Secured Loans | ||||
| Unsecured Loans | ||||
| Trade Payables | ||||
| Other Liabilities and Provisions | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Loans and Advances | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | 1.4% | |||
| Return on Partners' Funds | ||||
| Return on Assets | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Debt to Partners' Funds | ||||
| Interest Coverage | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Turnover Growth | ||||
| Profit Growth | ||||
To see the full financial statements and ratios of Canbio Pharmaceuticals LLP, buy the company report.
Designated partners of Canbio Pharmaceuticals LLP
Canbio Pharmaceuticals has 8 current designated partners and 6 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhupendrabhai Valjibhai Patel | Designated Partner | 12 Jun 2020 | 6 Years 5 Months | Current |
| Rabindra Kumar Mohanty | Designated Partner | 02 Sep 2020 | 6 Years 2 Months | Current |
| Bharatkumar Vitthalbhai Patel Also directs: Odhav Enviro Projects Limited | Designated Partner | 03 Oct 2024 | 2 Years 1 Months | Current |
| Pathik Bharatkumar Sheladia | Designated Partner | 01 Sep 2022 | 4 Years 2 Months | Current |
| Harsukhbhai Jasmatbhai Vekaria Also directs: Indo Multi Tradelink LLP, Petro Sol Multi Color LLP | Designated Partner | 12 Jun 2020 | 6 Years 5 Months | Current |
| Kishorkumar Vrajlal Rakholiya | Designated Partner | 03 Oct 2024 | 2 Years 1 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Dec 2024 | 101067909 | Icici Bank Limited | ₹75 Lakh | Open | |
| 24 Dec 2024 | 101067905 | Icici Bank Limited | ₹3.4 Cr | Open | |
| 15 Feb 2021 | 100416891 | Bank of Baroda | ₹3 Cr | Open |
To see the full charge records of Canbio Pharmaceuticals LLP, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Canbio Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Canbio Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Canbio Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAPFC4083N1ZZ | Gujarat | Active | 28 Jul 2020 |
To see the full GST registrations and return filing status of Canbio Pharmaceuticals LLP, buy the company report.
Recent activity
Canbio Pharmaceuticals LLP has 14 designated partner changes on record since 2020: 8 appointments and 6 cessations. The latest: Dwij Kishorbhai Rakholiya was appointed as Designated Partner on 01 Aug 2025.
9 earlier events are in the company report.
Frequently asked questions
Canbio Pharmaceuticals is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 12 June 2020 (6+ years old) and is registered under LLPIN AAS-5978.
Canbio Pharmaceuticals has 8 current designated partners:
- Bhupendrabhai Valjibhai Patel - Designated Partner
- Rabindra Kumar Mohanty - Designated Partner
- Bharatkumar Vitthalbhai Patel - Designated Partner
- Pathik Bharatkumar Sheladia - Designated Partner
- Harsukhbhai Jasmatbhai Vekaria - Designated Partner
- Kishorkumar Vrajlal Rakholiya - Designated Partner
- Dwij Kishorbhai Rakholiya - Designated Partner
- Rahul Rajaram Kondekar - Designated Partner
The latest financial statements of Canbio Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Canbio Pharmaceuticals is 24AAPFC4083N1ZZ, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Canbio Pharmaceuticals is AAS-5978. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Canbio Pharmaceuticals was incorporated on 12 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Dwij Kishorbhai Rakholiya was appointed as Designated Partner on 01 Aug 2025. Rahul Rajaram Kondekar was appointed as Designated Partner on 01 Aug 2025. Bharatkumar Vitthalbhai Patel was appointed as Designated Partner on 03 Oct 2024. Canbio Pharmaceuticals has 14 designated partner changes on record in total.
The registered office of Canbio Pharmaceuticals is at Plot No 247 248 1 Phase 1 G.I.D.C Naroda, Ahmedabad, Gujarat, India – 382330.
Canbio Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Canbio Pharmaceuticals has open charges of ₹7.15 Cr and no satisfied charges on record as per latest MCA filings.

